Seres Therapeutics posts corporate presentation at J.P. Morgan Conference; content not fully available

Seres Therapeutics, Inc.

Filed updated corporate presentation as Exhibit 99.1 on January 9, 2023.
Presentation dated January 2023 for 41st Annual J.P. Morgan Healthcare Conference.
CEO Eric Shaff featured; specific pipeline or financial details not included in excerpt.
No new material information can be confirmed from the limited exhibit text provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.